Please login to the form below

Not currently logged in

SK bioscience

This page shows the latest SK bioscience news and features for those working in and with pharma, biotech and healthcare.

GSK/SK bioscience COVID-19 vaccine to enter phase 3 trial

GSK/SK bioscience COVID-19 vaccine to enter phase 3 trial

South Korean company SK bioscience (SK)’s COVID-19 vaccine candidate, GBP510, will be compared directly to the AstraZeneca/Oxford University COVID-19 vaccine in a new clinical trial, GlaxoSmithKline (GSK) ... We are pleased to contribute with GSK’s

Latest news

More from news
Approximately 3 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Box 1
Strategic commitment
KOL Ambassador Program & Podcast Creation: A Customer Story
Animation: Living With
The journey from the patient's perspective...